Thu, January 7, 2021
Wed, January 6, 2021
Tue, January 5, 2021
Mon, January 4, 2021
Thu, December 31, 2020
Wed, December 30, 2020
Tue, December 29, 2020
Mon, December 28, 2020
Wed, December 23, 2020
Tue, December 22, 2020
Mon, December 21, 2020
Sun, December 20, 2020
Fri, December 18, 2020
Thu, December 17, 2020
Wed, December 16, 2020
Tue, December 15, 2020

Gregory Renza Downgraded (APRE) to Hold and Decreased Target to $200 on, Dec 29th, 2020


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. nd-decreased-target-to-200-on-dec-29th-2020.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Gregory Renza of RBC Capital, Downgraded "Aprea Therapeutics, Inc." (APRE) to Hold and Decreased Target from $800 to $200 on, Dec 29th, 2020.

Gregory has made no other calls on APRE in the last 4 months.



There are 2 other peers that have a rating on APRE. Out of the 2 peers that are also analyzing APRE, 1 agrees with Gregory's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Jeffrey Hung of "Morgan Stanley" Maintained at Hold with Decreased Target to $680 on, Wednesday, December 16th, 2020


This is the rating of the analyst that currently disagrees with Gregory


  • Esther Hong of "Berenberg" Initiated at Strong Buy and Held Target at $740 on, Wednesday, December 16th, 2020

Publication Contributing Sources